New Collaboration will Study Long-term Outcomes of CAR T-cell Therapy Yescarta
News
The Center for International Blood and Marrow Transplant Research (CIBMTR) and Kite Pharma recently agreed to collaborate on tracking long-term outcomes of patients treated with Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor ... Read more